Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 4 Next >
ALS and the crushing cost of care: How 4 Americans face the 'bankruptcy disease'
Tags Make It / Make It and Save Make It Biogen Inc
From CNBC.com News
Biogen advances Alzheimer's drug to late-stage trial despite disappointing data
Tags Health & Science Health care industry Biogen Inc
From CNBC.com News
Trump's pharmaceutical tariffs could affect some drugmakers more than others
Tags Health care industry Merck & Co Inc Pharmaceuticals
From CNBC.com News
FDA taps biotech industry veteran as RFK Jr.'s top drug regulator
Tags Biotechnology Social issues Amgen Inc
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Tags Breaking News: Markets Pro: Investing trends Investment strategy
From CNBC.com News
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
Tags Breaking News: Business Breaking News: Earnings Health & Science
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Economy Markets Coca/Cola Co
From CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Tags Biotechnology Eisai Co Ltd LILLY DRN
From CNBC.com News
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
Tags Biotech and Pharmaceuticals Companies US: News
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags Toll Brothers Inc stocks Investment strategy
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Comcast Corp Technology Politics
From CNBC.com News
Thursday's big stock stories: What's likely to move the market in the next trading session
Tags Live Nation Entertainment Inc WW Grainger Inc Howmet Aerospace Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Investment strategy 5 Things to Know Markets
From CNBC.com News
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
Tags Health care industry Breaking news Science
From CNBC.com News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
Tags Biotechnology Breaking news Health care industry
From CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
Tags Eisai Co Ltd Biotechnology Business News
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Biotech and Pharmaceuticals US: News Companies
From CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
Tags Biogen Inc US: News Companies
From CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
Tags U/S/ Markets Investment Strategy Eisai Co Ltd
From CNBC.com News
Cramer's Lightning Round: Bank of America is a buy
Tags Investment Strategy U/S/ Markets S&P 500
From CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
Tags Biogen Inc Breaking news Health care industry
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Technology Tesla Inc Hasbro Inc
From CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
Tags US: News Companies Pharmaceuticals
From CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
Tags Health care industry Biogen Inc Science
From CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
Tags Biogen Inc Breaking news Health care industry
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Politics Tesla Inc DoorDash Inc
From CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
Tags Science Pharmaceuticals Business News
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags Pharmaceuticals Business News Business
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Biogen Inc Markets Berkshire Hathaway Inc
From CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
Tags Companies US: News Biotech and Pharmaceuticals
From CNBC.com News
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.